WHO Grade 3 Glioma — Research

WHO Grade 3 Glioma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-13	367	`("WHO Grade 3 Glioma"[tiab] OR "Anaplastic Glioma"[tiab] OR "WHO Grade III Glioma"[tiab])`	2026-09-13	pubmed
Last 5 years	2021-01-01 → 2026-12-31	55	`("WHO Grade 3 Glioma"[tiab] OR "Anaplastic Glioma"[tiab] OR "WHO Grade III Glioma"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-13	pubmed
Last 12 months	2025-09-13 → 2026-09-13	9	`("WHO Grade 3 Glioma"[tiab] OR "Anaplastic Glioma"[tiab] OR "WHO Grade III Glioma"[tiab]) AND (2025/09/13:2026/09/13[dp])`	2026-09-13	pubmed

Data updated 17 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (8)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–8 of 8 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

IDH1 and IDH2 mutations in gliomas.
· N Engl J Med · 2009 · PMID 19228619 · validated civic_curation pubmed
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
· Neuro Oncol · 2022 · PMID 35395680 · validated civic_curation pubmed
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide.
· Neurology · 2009 · PMID 19933982 · validated civic_curation pubmed
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.
· Acta Neuropathol · 2013 · PMID 23904111